Genetic disorders with both hearing loss and cardiovascular abnormalities

Advances in Oto-Rhino-Laryngology

Volumn 70, Issue , 2011, Pages 66-74

  Belmont, John W ^a,b   Craigen, William ^a   Martinez, Hugo ^a   Jefferies, John Lynn ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CHILDREN S NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENETICS; HAIR CELL; HEARING LOSS; HUMAN; INNER EAR; MIDDLE EAR; MUTATION; SYNDROME;

EAR, INNER; EAR, MIDDLE; HAIR CELLS, AUDITORY; HEARING LOSS; HEART DEFECTS, CONGENITAL; HUMANS; MITOCHONDRIAL DISEASES; MUTATION; SYNDROME;

EID: 79952415883     PISSN: 00653071     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000322474     Document Type: Article

References (57)

1. Emanuel BS, McDonald- McGinn D, Saitta SC, Zackai EH: The 22q11.2 deletion syndrome. Adv Pediatr 2001;48: 39-73.
2. Vantrappen G, Rommel N, Swillen A, Cremers CW, Fryns JP, Devriendt K: Velo- cardio- facial syndrome: guidelines for diagnosis, treatment and follow- up of ent manifestations. Acta Otorhinolaryngol Belg 2003;57:101-106. (Pubitemid 36693208)
3. Dyce O, McDonald- McGinn D, Kirschner RE, Zackai E, Young K, Jacobs IN: Otola ryngologic manifestations of the 22q11.2 deletion syndrome. Arch Otolaryngol Head Neck Surg 2002;128: 1408-1412. (Pubitemid 35424675)
4. Momma K: Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome. Am J Cardiol 2010;105:1617-1624.
5. Gajecka M, Mackay KL, Shaffer LG: Monosomy 1p36 deletion syndrome. Am J Med Genet C Semin Med Genet 2007; 145C:346-356. (Pubitemid 350155973)
6. Battaglia A, Hoyme HE, Dallapiccola B, Zackai E, Hudgins L, McDonald- McGinn D, Bahi- Buisson N, Romano C, Williams CA, Brailey LL, Zuberi SM, Carey JC: Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation. Pediatrics 2008;121:404-410. (Pubitemid 351198468)
7. Rosenfeld JA, Crolla JA, Tomkins S, Bader P, Morrow B, Gorski J, Troxell R, Forster- Gibson C, Cilliers D, Hislop RG, Lamb A, Torchia B, Ballif BC, Shaffer LG: Refinement of causative genes in monosomy 1p36 through clinical and molecular cytogenetic characterization of small interstitial deletions. Am J Med Genet A 2010;152A:1951-1959.
8. Bergemann AD, Cole F, Hirschhorn K: The etiology of Wolf- Hirschhorn syndrome. Trends Genet 2005;21:188-195. (Pubitemid 40269858)
9. Ulualp SO, Wright CG, Pawlowski KS, Roland PS: Histopathological basis of hearing impairment in Wolf- Hirschhorn syndrome. Laryngoscope 2004;114: 1426-1430. (Pubitemid 39045516)
10. Lesperance MM, Grundfast KM, Rosenbaum KN: Otologic manifestations of Wolf- Hirschhorn syndrome. Arch Otolaryngol Head Neck Surg 1998;124: 193-196. (Pubitemid 28087899)
11. Battaglia A, Filippi T, Carey JC: Update on the clinical features and natural history of Wolf- Hirschhorn (4p- ) syndrome: experience with 87 patients and recommendations for routine health supervision. Am J Med Genet C Semin Med Genet 2008;148C:246-251.
12. Lin RJ, Cherry AM, Chen KC, Lyons M, Hoyme HE, Hudgins L: Terminal deletion of 6p results in a recognizable phenotype. Am J Med Genet A 2005;136: 162-168. (Pubitemid 40967107)
13. Davies AF, Mirza G, Sekhon G, Turnpenny P, Leroy F, Speleman F, Law C, van Regemorter N, Vamos E, Flinter F, Ragoussis J: Delineation of two distinct 6p deletion syndromes. Hum Genet 1999;104:64-72. (Pubitemid 29134643)
14. Martens MA, Wilson SJ, Reutens DC: Research Review: Williams syndrome: a critical review of the cognitive, behavioral, and neuroanatomical phenotype. J Child Psychol Psychiatry 2008;49: 576-608. (Pubitemid 351713313)
15. Marler JA, Sitcovsky JL, Mervis CB, Kistler DJ, Wightman FL: Auditory function, hearing loss in children and adults with Williams syndrome: cochlear impairment in individuals with otherwise normal hearing. Am J Med Genet C 2010;154C:249-265.
16. Cherniske EM, Carpenter TO, Klaiman C, Young E, Bregman J, Insogna K, Schultz RT, Pober BR: Multisystem study of 20 older adults with Williams syndrome. Am J Med Genet A 2004;131: 255-264.
17. Marler JA, Elfenbein JL, Ryals BM, Urban Z, Netzloff ML: Sensorineural hearing loss in children and adults with Williams syndrome. Am J Med Genet A 2005;138:318-327. (Pubitemid 41532948)
18. Collins RT, 2nd, Kaplan P, Somes GW, Rome JJ: Cardiovascular abnormalities, interventions, and long- term outcomes in infantile Williams syndrome. J Pediatr 2010;156:253- 258, e251.
19. Mikuni H, Ushiki T, Abe K, Fukuda S, Inuyama Y: Nature of the fine fibrils of the basilar membrane in the cochlea. Arch Histol Cytol 1994;57:187-191 (Pubitemid 24196208)
20. Pagon RA, Zonana J, Graham JM: CHARGE association. Pediatrics 1982; 70:827-828.
21. Sanlaville D, Verloes A: CHARGE syndrome: an update. Eur J Hum Genet 2007;15:389-399. (Pubitemid 46487692)
22. Wiener- Vacher SR, Amanou L, Denise P, Narcy P, Manach Y: Vestibular function in children with the CHARGE association. Arch Otolaryngol Head Neck Surg 1999;125:342-347. (Pubitemid 29133702)
23. Guyot JP, Gacek RR, DiRaddo P: The temporal bone anomaly in CHARGE association. Arch Otolaryngol Head Neck Surg 1987;113:321-324. (Pubitemid 17023602)
24. Blake KD, Prasad C: CHARGE syndrome. Orphanet J Rare Dis 2006;1:34.
25. Zentner GE, Layman WS, Martin DM, Scacheri PC: Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A 2010; 152A:674-686.
26. Lalani SR, Safiullah AM, Fernbach SD, et al: Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype- phenotype correlation. Am J Hum Genet 2006;78:303-314. (Pubitemid 43157569)
27. Powell CM, Michaelis RC: Townes- Brocks syndrome. J Med Genet 1999;36: 89-93. (Pubitemid 29101380)
28. OCallaghan M, Young ID: The Townes- Brocks syndrome. J Med Genet 1990;27: 457-461.
29. Botzenhart EM, Green A, Ilyina H, et al: SALL1 mutation analysis in Townes- Brocks syndrome: twelve novel mutations and expansion of the phenotype. Hum Mutat 2005;26:282.
30. Smith RS, Zabaleta A, Kume T, Savinova OV, Kidson SH, Martin JE, Nishimura DY, Alward WL, Hogan BL, John SW: Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development. Hum Mol Genet 2000;9:1021-1032. (Pubitemid 30216007)
31. van der Burgt I: Noonan syndrome. Orphanet J Rare Dis 2007;2:4.
32. Schubbert S, Bollag G, Shannon K: Deregulated Ras signaling in developmental disorders: new tricks for an old dog. Curr Opin Genet Dev 2007;17: 15-22. (Pubitemid 46109294)
33. Cremers CW, van der Burgt CJ: Hearing loss in Noonan syndrome. Int J Pediatr Otorhinolaryngol 1992;23:81-84.
34. Sznajer Y, Keren B, Baumann C, Pereira S, Alberti C, Elion J, Cave H, Verloes A: The spectrum of cardiac anomalies in Noonan syndrome as a result of mutations in the PTPN11 gene. Pediatrics 2007;119:e1325-e1331. (Pubitemid 46871252)
35. Tidyman WE, Rauen KA: The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev 2009;19:230-236.
36. Goldenberg I, Moss AJ, Zareba W, McNitt S, Robinson JL, Qi M, Towbin JA, Ackerman MJ, Murphy L: Clinical course and risk stratification of patients affected with the Jervell and Lange- Nielsen syndrome. J Cardiovasc Electrophysiol 2006;17:1161-1168. (Pubitemid 44583855)
37. Duggal P, Vesely MR, Wattanasirichaigoon D, Villafane J, Kaushik V, Beggs AH: Mutation of the gene for IsK associated with both Jervell and Lange- Nielsen and Romano- Ward forms of Long- QT syndrome. Circulation 1998;97:142-146. (Pubitemid 28124670)
38. Sarkozy A, Digilio MC, Dallapiccola B: Leopard syndrome. Orphanet J Rare Dis 2008;3:13.
39. Limongelli G, Pacileo G, Marino B, Digilio MC, Sarkozy A, Elliott P, Versacci P, Calabro P, De Zorzi A, Di Salvo G, Syrris P, Patton M, McKenna WJ, Dallapiccola B, Calabro R: Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome. Am J Cardiol 2007;100:736-741. (Pubitemid 47223154)
40. Limongelli G, Sarkozy A, Pacileo G, Calabro P, Digilio MC, Maddaloni V, Gagliardi G, Di Salvo G, Iacomino M, Marino B, Dallapiccola B, Calabro R: Genotype- phenotype analysis and natural history of left ventricular hypertrophy in LEOPARD syndrome. Am J Med Genet A 2008;146A: 620-628.
41. Tartaglia M, Gelb BD: Noonan syndrome and related disorders: genetics and pathogenesis. Annu Rev Genomics Hum Genet 2005;6:45-68. (Pubitemid 41397075)
42. Digilio MC, Conti E, Sarkozy A, Mingarelli R, Dottorini T, Marino B, Pizzuti A, Dallapiccola B: Grouping of multiple- lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet 2002;71:389-394. (Pubitemid 34800254)
43. Sarkozy A, Carta C, Moretti S, et al: Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. Hum Mutat 2009;30:695-702.
44. Pandit B, Sarkozy A, Pennacchio LA, et al: Gain- of- function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet 2007;39:1007-1012. (Pubitemid 47185177)
45. Welsh LW: Alstrom syndrome: progressive deafness and blindness. Ann Otol Rhinol Laryngol 2007;116:281-285. (Pubitemid 46656063)
46. Marshall JD, Beck S, Maffei P, Naggert JK: Alstrom syndrome. Eur J Hum Genet 2007;15:1193-1202.
47. Weinstein R: Phytanic acid storage disease (Refsum disease): clinical characteristics, pathophysiology and the role of therapeutic apheresis in its management. J Clin Apher 1999;14:181-184. (Pubitemid 30020638)
48. Kokotas H, Petersen MB, Willems PJ: Mitochondrial deafness. Clin Genet 2007;71:379-391. (Pubitemid 46730646)
49. Finsterer J: Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation. Acta Neurol Scand 2007;116: 1-14. (Pubitemid 46976273)
50. Khanim F, Kirk J, Latif F, Barrett TG: WFS1/wolframin mutations, Wolfram syndrome, and associated diseases. Hum Mutat 2001;17:357-367. (Pubitemid 32381669)
51. Rigoli L, Lombardo F, Di Bella C: Wolfram syndrome and WFS1 gene. Clin Genet 2010 Aug 12 [Epub ahead of print].
52. Pijl S, Westerberg BD: Cochlear implantation results in patients with Kearns- Sayre syndrome. Ear Hear 2008;29:472-475. (Pubitemid 351652241)
53. Marin- Garcia J, Goldenthal MJ, Flores- Sarnat L, Sarnat HB: Severe mitochondrial cytopathy with complete A- V block, PEO, and mtDNA deletions. Pediatr Neurol 2002;27:213-216. (Pubitemid 35254128)
54. Gibson K, Halliday JL, Kirby DM, Yaplito- Lee J, Thorburn DR, Boneh A: Mitochondrial oxidative phosphorylation disorders presenting in neonates: clinical manifestations and enzymatic and molecular diagnoses. Pediatrics 2008;122:1003-1008.
55. Wold SM, Derkay CS, Darrow DH, Proud V: Role of the pediatric otolaryngologist in diagnosis and management of children with mucopolysaccharidoses. Int J Pediatr Otorhinolaryngol 2010;74:27-31.
56. Muenzer J, Wraith JE, Clarke LA: Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 2009;123:19-29.
57. Bonita RE, Cohen IS, Berko BA: Valvular heart disease in osteogenesis imperfecta: presentation of a case and review of the literature. Echocardiography 2010; 27:69-73.